Articles tagged with Ampa Receptors
Researchers developed a novel fluorescent probe to visualize AMPA receptors on living brain cells, revealing that new receptors are inserted from inside the cell during long-term potentiation. This breakthrough allows for rapid study of synapse strength and plasticity, shedding light on memory formation and learning.
A new study by McGill University researchers sheds light on the disruption of calcium transport in the brain's AMPA receptors, linking it to autism and intellectual disability. The findings could pave the way for treatments targeting these receptors, offering hope for patients with related neurological disorders.
Scientists have used a cryo-electron microscope to capture detailed images of glutamate molecules interacting with AMPA receptors, revealing the chemical flow that enables learning and thinking in brain cells. The findings could lead to the development of new drugs to treat conditions like epilepsy and intellectual disorders.
Researchers developed a method to visualize AMPA receptors using PET scans, revealing differences in density and distribution between healthy subjects and those with psychiatric disorders. This discovery may lead to new diagnostic and therapeutic approaches for conditions like schizophrenia, bipolar disorder, and autism spectrum disorder.
Researchers from Johns Hopkins Medicine discovered how a brain cell surface molecule shapes neuron behavior, finding that it suppresses selectivity in neurons. The study's findings may help scientists better understand causes of autism, schizophrenia, and epilepsy.
Scientists at Johns Hopkins Medicine have discovered the mechanism of action of the widely-used epilepsy drug perampanel, which targets the AMPA receptor to dampen brain cell excitability. The study provides new insights into the potential applications of perampanel in treating other neurological conditions such as Alzheimer’s disease,...
Researchers have developed a new method to label naïve neurotransmitter receptor proteins in living animal brains without genetic manipulation. This technique, known as ligand-directed acylimidazole chemistry (LDAI chemistry), uses pulse-chase analysis to track the movement and fate of proteins in real-time.
A recent study published in Neuron reveals that Noelin proteins play a crucial role in learning and memory formation in the mammalian brain. The study found that these proteins act as 'universal anchors' controlling the distribution and dynamics of AMPA receptors, which are essential for synaptic plasticity.
Researchers found reduced editing efficiency of GluA2 mRNA in ALS patients' cerebrospinal fluid, correlating with longer disease duration and advanced symptoms. This discovery could lead to the development of therapies targeting RNA editing for treatable ALS cases.
Dr. Jayaraman's team will analyze glutamate receptors involved in learning and memory processes, shedding light on pathologies of learning disabilities, epilepsy, and other neurological issues.
Researchers develop system to image millions of brain cell connections in real-time, revealing key locations for learning and memory encoding. The new tool allows scientists to study synapse activity on a massive scale, with potential applications in understanding diseases such as Alzheimer's and autism.
A study found that LSD enhances social behavior in mice by increasing excitatory neurotransmission in the medial prefrontal cortex. The neurobiological mechanisms underlying LSD's prosocial effects are unclear but may be linked to the mTORC1 protein complex.
A POSTECH research team identified the mechanism behind neurological diseases such as dementia, autism, and schizophrenia. They found that BDNF regulates AMPA receptors, which are crucial for synaptic function in nerve cells. The study provides clues to treating development or degenerative brain diseases like autism and dementia.
Scientists discovered that AMPA receptors continually form and disintegrate within a fraction of a second, allowing for novel mechanisms of synaptic plasticity to occur. This finding may lead to the development of new treatments for epilepsy by targeting specific subunit compositions in the brain.
Scientists have discovered the native structure of AMPA receptors in rodent models, which may lead to new insights into neurodegenerative diseases such as Alzheimer's. The research could provide novel approaches for therapies by understanding how these receptors differ in people with devastating diseases.
Researchers found that when one synapse strengthens, neighboring synapses weaken due to the action of a crucial protein called Arc. This balance is essential for maintaining healthy neural activity and function. The discovery provides new insights into how brain plasticity works in complex systems.
A Penn Medicine study reveals that early-life seizures can lead to premature activation of synapses tied to learning and language skills in children with autism. The researchers found that an antiepileptic drug may keep these synapses 'silent' longer, allowing the brain to develop normally.
Researchers at UC Davis identified SynDIG4 protein as a crucial regulator of synaptic plasticity, enabling the formation and consolidation of new memories. The discovery sheds light on the molecular mechanisms underlying memory formation and could lead to novel therapeutic strategies for cognitive disorders.
Researchers captured three-dimensional snapshots of the AMPA-subtype glutamate receptor in action, shedding light on its role in memory and learning. The study's findings provide new insights into the fundamental process involved in brain function.
Researchers at Columbia University have obtained detailed images of AMPA receptor interactions with regulatory proteins, revealing the structural changes that occur during desensitization. This knowledge may aid in designing targeted therapies for conditions like Alzheimer's, Parkinson's, epilepsy, and schizophrenia.
A new study at McGill University reveals that complex interactions between neurotransmitter receptors and other proteins help explain the brain's ability to process information quickly. Researchers used multiple techniques to examine AMPA receptors, a major player in brain signaling.
Researchers at Johns Hopkins University developed a technique to visualize AMPA receptors in live mice, revealing that tickling increases receptor levels and strengthens synapses. This discovery has broad applications for studying learning and neurological disorders like autism, Alzheimer's disease, and schizophrenia.
Researchers discovered a link between blood pressure hormone angiotensin and psychosis, while finding that increased cysteine levels may alleviate symptoms in people with Huntington's disease. Additionally, drugs targeting AMPA receptors improved social behaviors in autistic mice.
A study has identified a potential treatment target for cocaine addiction by revealing that altering a specific receptor protein can reduce cocaine seeking in animal models. Increasing the expression of an enzyme within the GluA2 subunits of AMPA receptors decreased cocaine seeking in animals allowed to self-administer the drug.
Researchers discovered that CKAMP44 and TARP Gamma-8 proteins play a crucial role in controlling the flow of information into the hippocampus, a brain region essential for learning and memory. The proteins influence glutamate receptor activity, promoting or weakening synaptic connections, and enabling rapid sequence of signals.
Researchers found that protein erbin is critical to excitement in inhibitory brain cells, enabling them to suppress activity. The discovery sheds new light on schizophrenia and seizures, highlighting the importance of balance between excitation and inhibition.
Researchers found that specific receptor variants determine the development of nerve cells' dendrites, a crucial mechanism for communication. Different cell classes use these variants to grow dendrites in unique ways.
Researchers found that kibra protein is essential for regulating brain circuitry and learning, leading to impaired memory in mice lacking the protein. The study suggests that kibra plays a crucial role in shaping brain connections during learning and memory formation.
Scientists used single molecule fluorescence resonance energy transfer (FRET) techniques combined with wavelet transforms to study the AMPA receptor's behavior. They identified four distinct conformations of the receptor and found that its 'cleft' is constantly opening and closing, exploring space for neurotransmitters.
A team of researchers at the University of Illinois has identified a promising new drug target for Alzheimer's disease: the beta-2 adrenergic receptor. The receptor is activated by amyloid-beta, leading to increased activity in affected neurons and eventual cell death.
Researchers at Johns Hopkins School of Medicine have discovered that the AMPA receptor protein moves to its destination with the help of the 4.1N protein, forming long-term memories. The study found that 4.1N is required to maintain strong connections between neurons, making memories stick.
A new technique allows researchers to identify the specific neural connections and molecular tags that sustain a particular fear memory in mice. The study reveals how proteins called AMPA receptors strengthen memories by becoming part of the synapses encoding them.
Scientists at UCSD School of Medicine identified a potential new therapy for chronic spasticity and rigidity, a painful condition often resulting from spinal cord injuries. They found that the AMPA receptor antagonist NGX424 suppresses spasticity and rigidity in rats, providing a novel means of reducing muscle tone.
A new study reveals that blocking NMDA receptors leads to an increase in AMPA activity, which is crucial for ketamine's rapid antidepressant effects. This finding suggests that targeting AMPA directly may lead to the development of faster-acting antidepressants with fewer side effects.
A University of Utah study suggests that proteins serve as anchors, holding other proteins in place to strengthen synapses and contribute to forming and retaining memories. The research is relevant not only to how memory and learning work but also to Alzheimer's disease, which involves a breakdown in protein movement within synapses.
Researchers identified two critical molecular events: PICK1's role in removing AMPA receptors and phosphorylation's effect on the receptor. These findings provide new understanding of long-term depression and its connection to motor learning, such as the vestibulo-ocular reflex.
A recent Carnegie Mellon University study has verified synaptic plasticity in a living animal's brain for the first time, pointing to future avenues for understanding the learning process. The research reveals that experience-dependent changes occur in AMPA receptors at specific synapses, altering their properties and subunit composition.
Researchers have found a way to protect vulnerable neurons in the hippocampus from stroke damage by correcting a specific molecular malfunction. By targeting the AMPA receptor subunit editing machinery, they can prevent calcium influx and subsequent neuronal injury.
Researchers at UCSF have discovered that the brain refreshes its supply of memory-making molecules by migrating receptors along neurons to synapses. This process supports rapid changes in the number of receptors during learning and memory formation, contradicting previous assumptions about receptor replacement.
Researchers found that AMPA receptors play a crucial role in regulating nerve cell responses to pain stimulation during inflammatory conditions. The study showed that mice with increased or decreased permeability of AMPA channels exhibited distinct pain responses to heat and mechanical pressure on inflamed paws.
The study reveals that recycling endosomes transport molecular cargo to the neuronal surface after being drawn into the neuron, regulating long-term potentiation (LTP) and spine growth. This discovery suggests a unifying mechanism for understanding LTP and its role in learning and memory.
Researchers at Brown University have discovered that recycling endosomes store and transport AMPA receptors, which are essential for memory formation. The study provides new targets for treatments for disorders such as Alzheimer's disease and mental retardation.
A team of scientists has identified a protein called Dasm1 that plays a crucial role in regulating dendritic spine growth and synapse maturation. The discovery sheds light on the mechanisms underlying brain development and memory formation, suggesting a potential control molecule for both processes.
Researchers have found a new therapeutic target for stroke by blocking calcium-permeable AMPA receptors, which cause neuronal death. Introducing a form of GluR2 that renders AMPA receptors impermeable to calcium protects vulnerable neurons from ischemia.
A new study evaluates CX516, an Ampakine compound, to enhance glutamate transmission in the brain for fragile X syndrome and autism. The trial aims to improve cognitive deficits associated with these diseases.
Researchers have discovered long-term potentiation, a brain process that strengthens connections and promotes memory. This process involves the rapid relocation of receptors in synapses, leading to increased synaptic transmission and potentially explaining why memory can falter.
Neurons control connection strength by removing or inserting receptors for glutamate, a key neurotransmitter. The discovery reveals a 'shuttle' system that rapidly regulates receptor numbers, allowing neurons to adjust connection strength.
Researchers at Cold Spring Harbor Laboratory uncovered a new link in the molecular chain of events thought to underlie learning and memory. Strengthening of nerve cell connections can be largely explained by the movement of AMPA receptors into synapses.
Scientists have identified a network of cellular receptors in the spinal cord that transmits sensations of chronic pain. Blocking their activity may provide a new strategy for pain management. The discovery suggests that pain can be caused by pathways normally not painful.
Researchers discovered that oligodendrocytes, responsible for white matter protection, are vulnerable to elevated levels of glutamate after brain or spinal cord injury. Compounds that block glutamate's action may prevent this damage and improve day-to-day function for people with spinal cord injuries.
Researchers at Johns Hopkins Medicine have identified a protein called GRIP that clusters neurotransmitter receptors together on brain cells, enabling faster and stronger communication between nerve cells. This discovery has the potential to play a role in learning and memory.